Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia
Amber Afzal, Mark A. Fiala, Meagan A. Jacoby, Matthew J. Walter
Topics & Concepts
Myelodysplastic syndromesLeukemiaMedicineOncologyInternal medicineHydroxymethylglutaryl-CoA Reductase InhibitorsStatinCancer researchImmunologyBone marrowAcute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes